Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle Cell Trait, Disease Linked With Faster Kidney Function Decline in African American Patients
source: The American Journal of Managed Care
year: 2020
authors: Matthew Gavidia
summary/abstract:Sickle-cell trait (SCT) and disease (SCD) among African American patients were associated with a faster kidney function decline, with SCD contributing to a more rapid decline, according to study findings published in the Journal of the American Society of Nephrology.1
According to the CDC, SCD affects approximately 100,000 Americans and is most common in African-Americans (1 out of every 365 births) and Hispanic-Americans (1 out of every 16,300 births). SCT, characterized by 1 copy of the altered hemoglobin gene compared with SCD’s 2 copies, additionally is found most prominently in African-Americans, affecting up to 8% to 10% of the population.
As study authors note, prior studies have described the association between sickle hemoglobin and chronic kidney disease (CKD), but there is limited understanding of the effect of sickle hemoglobin on the decline in estimated glomerular filtration rate (eGFR) over time compared with a population with no sickle hemoglobin. eGFR, a marker of disease severity and associated comorbid conditions, has been shown to be an accurate predictor of prognosis of renal failure in patients with type 2 diabetes, indicating its potential screening importance among patients with SCD/SCT.
Researchers conducted a multicenter, observational study using registry data collected from January 2005 to June 2018 from adult black patients with SCT (n = 1251) or SCD (n = 230), distinguished as exposures, and reference patients with normal hemoglobin phenotype status (n = 8729).
read more
+myBinderRelated Content
-
Nutcracker Syndrome and Sickle Cell Trait: A Perfect Storm for HematuriaWe describe the case of a 27-year-old wo...
-
Sickle Cell TraitPeople who inherit one sickle cell gene ...
-
National Sickle Cell Disease Poll of African Americans Dispels Long-Held ViewsPfizer Inc. (NYSE:PFE), the National New...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
Ayòbámi Adébáyò on how having the sickle cell trait inspired her bestselling debutIt has been quite a year for Ayòbámi A...
-
Ty Montgomery says he’s not worried about sickle cell traitThe symptoms that kept Ty Montgomery out...
-
Sickle Cell Disease: After Years of Neglect Some Promise for SufferersIt’s Black History Month, when the nat...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.